StockNews.com started coverage on shares of Arch Biopartners (NYSE:ARCH – Free Report) in a report released on Monday. The firm issued a hold rating on the stock.
Arch Biopartners Stock Performance
Shares of NYSE:ARCH opened at $134.83 on Monday. Arch Biopartners has a 52 week low of $116.44 and a 52 week high of $180.65.
Read More
- Five stocks we like better than Arch Biopartners
- 10 Best Airline Stocks to Buy
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- What is the Australian Securities Exchange (ASX)
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
